Familial calcium pyrophosphate dihydrate deposition disease and the ANKH gene
- PMID: 12707589
- DOI: 10.1097/00002281-200305000-00023
Familial calcium pyrophosphate dihydrate deposition disease and the ANKH gene
Abstract
The crystal deposition arthropathies comprise a host of disorders that may occur idiopathically or as secondary manifestations of associated diseases. Rarely, crystal deposition presents as a familial disorder. Most affected family members display radiographically detectable crystals of calcium pyrophosphate dihydrate in their joint spaces. In genetic studies of familial calcium pyrophosphate dihydrate deposition disease, a region on the short arm of chromosome 5 was found to be genetically linked to the phenotype displayed by several of these families. Among the positional candidates at this locus was ANKH, the human homolog of a gene that is responsible for the phenotype of progressive ankylosis (ank) in the mouse. ANKH codes for a transmembrane protein that appears to regulate the transport of inorganic pyrophosphate. It was analyzed as a potential positional candidate gene for calcium pyrophosphate dihydrate deposition disease, and in several unrelated families, sequence variants were identified that segregated with the calcium pyrophosphate dihydrate deposition disease phenotype among affected members. A discussion of ANKH as the familial calcium pyrophosphate dihydrate deposition disease gene is presented.
Similar articles
-
P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells.Arthritis Res Ther. 2006;8(6):R164. doi: 10.1186/ar2072. Arthritis Res Ther. 2006. PMID: 17067391 Free PMC article.
-
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.Am J Hum Genet. 2002 Oct;71(4):985-91. doi: 10.1086/343053. Epub 2002 Sep 17. Am J Hum Genet. 2002. PMID: 12297989 Free PMC article.
-
The ANKH gene and familial calcium pyrophosphate dihydrate deposition disease.Joint Bone Spine. 2004 Sep;71(5):365-8. doi: 10.1016/j.jbspin.2004.01.011. Joint Bone Spine. 2004. PMID: 15474385 Review.
-
Genetics of chondrocalcinosis.Osteoarthritis Cartilage. 2005 Sep;13(9):745-50. doi: 10.1016/j.joca.2005.04.006. Osteoarthritis Cartilage. 2005. PMID: 15951203 Review.
-
Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.Am J Hum Genet. 1999 Jan;64(1):136-45. doi: 10.1086/302186. Am J Hum Genet. 1999. PMID: 9915952 Free PMC article.
Cited by
-
P5L mutation in Ank results in an increase in extracellular inorganic pyrophosphate during proliferation and nonmineralizing hypertrophy in stably transduced ATDC5 cells.Arthritis Res Ther. 2006;8(6):R164. doi: 10.1186/ar2072. Arthritis Res Ther. 2006. PMID: 17067391 Free PMC article.
-
Nonpharmacologic and pharmacologic management of CPP crystal arthritis and BCP arthropathy and periarticular syndromes.Rheum Dis Clin North Am. 2014 May;40(2):343-56. doi: 10.1016/j.rdc.2014.01.010. Epub 2014 Feb 19. Rheum Dis Clin North Am. 2014. PMID: 24703351 Free PMC article. Review.
-
The Role of ANK in Calcium Pyrophosphate Deposition Disease.Curr Rheumatol Rep. 2016 May;18(5):25. doi: 10.1007/s11926-016-0574-z. Curr Rheumatol Rep. 2016. PMID: 27032788 Free PMC article. Review.
-
Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification.Purinergic Signal. 2006 Jun;2(2):371-7. doi: 10.1007/s11302-005-5304-3. Epub 2006 Jun 1. Purinergic Signal. 2006. PMID: 18404477 Free PMC article.
-
Matrix vesicles from chondrocytes and osteoblasts: Their biogenesis, properties, functions and biomimetic models.Biochim Biophys Acta Gen Subj. 2018 Mar;1862(3):532-546. doi: 10.1016/j.bbagen.2017.11.005. Epub 2017 Nov 3. Biochim Biophys Acta Gen Subj. 2018. PMID: 29108957 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
